Miro Viitala
- A form of inherited hyperferritinemia associated with bi-allelic pathogenic variants of STAB1 (2023)
- American Journal of Human Genetics
- Makrofagit älykkäästi mukaan syövän hoitoon (2023)
- Duodecim
- Re-educating macrophages to activate antitumor immunity: One Clever Immunotherapy (2023) Viitala Miro
- Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial (2021)
- Clinical Cancer Research
- Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8(+) T-cell Response against Immunosuppressive Tumors (2019)
- Clinical Cancer Research
- Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice (2018)
- Frontiers in Immunology
- Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E-/- Mice (2018)
- Arteriosclerosis, Thrombosis, and Vascular Biology
- High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer (2016)
- Journal of Molecular Biochemistry